Tuberculosis and public health - public hearing
Unlike the Avian Flu, which, luckily, constitutes only a risk, tuberculosis (TB) kills 1.7 million people each year and we are witnessing the development of so called "resistant" or "super-resistant" – and, in many cases, mortal - forms of tuberculosis. The development of multi-drug resistant TB (a strain on which two classes of antibiotics have no effect) and extensively-drug resistant TB (for which three antibody classes are ineffective) is a cause of concern to the WHO and has been the subject of worrying publications. It therefore seemed useful to Ms. Marie-Christine Blandin, Senator, and Mr. Jean-Pierre Door, Deputy, co-authors in 2005 of a report on the risk of an epidemic, to complete this work with a public hearing, to allow for a survey of the situation in France, the projects for fighting this disease, and the prospects provided by research.
Short title:
Tuberculosis
Start date:
2007-02
End date:
2007-02
Homepage:
http://www.assemblee-nationale.fr/12/cr-oecst/06-07/english_tuberculose.pdf
Focus:
Expert-based, Governance, Health, Medical technology, Parliament involvement, Public participation, Risk
Project leader:
Office Parlementaire d´Evaluation des Choix Scientifiques et Technologiques of the French Parliament (OPECST)
Country:
FR

 Back